You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 9,352,025


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,352,025 protect, and when does it expire?

Patent 9,352,025 protects CYCLOSET and is included in one NDA.

This patent has ten patent family members in seven countries.

Summary for Patent: 9,352,025
Title:Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
Abstract: The present invention is directed to a method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the use of an agent(s) that increases central dopaminergic activity plus a first-phase insulin secretagouge.
Inventor(s): Cincotta; Anthony H. (Tiverton, RI)
Assignee: VeroScience LLC (Tiverton, RI)
Application Number:14/506,353
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,352,025: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 9,352,025, exploring its claims, scope, and the broader patent landscape.

Overview of United States Patent 9,352,025

Patent Title and Abstract

United States Patent 9,352,025, titled "Method of treating a metabolic disorder," outlines a method for treating metabolic disorders using specific therapeutic approaches. The abstract provides a brief summary of the invention, highlighting the key elements and the intended use of the method[5].

Claims

The claims section of a patent is critical as it defines the legal boundaries of the invention. For US Patent 9,352,025, the claims would typically include:

  • Independent Claims: These define the broadest scope of the invention.
  • Dependent Claims: These narrow down the scope by adding additional limitations to the independent claims.
  • Method Claims: These specify the steps involved in the method of treating metabolic disorders.

Analyzing the Claims

Claim Structure

To analyze the claims, one must understand the structure and dependency between them. The Patent Claims Research Dataset provided by the USPTO can offer insights into claim-level statistics and document-level statistics, which can be applied to understand the scope and complexity of the claims in US Patent 9,352,025[3].

Claim Scope

The scope of the claims determines what is protected under the patent. For a method patent like US 9,352,025, the scope would include the specific steps and elements necessary to treat metabolic disorders. Any variations or modifications that fall within the scope of these claims would be considered infringing.

Patent Landscape Analysis

Patent Classification

Patent classification systems, such as those used by the USPTO and international offices, help organize patents into specific technology groupings. Understanding the classification of US Patent 9,352,025 can help identify similar patents and technologies in the metabolic disorder treatment field[4].

Prior Art and Citation Data

The Common Citation Document (CCD) application and Global Dossier services provided by the USPTO and other international patent offices can help identify prior art and citation data related to the patent. This information is crucial for understanding the novelty and non-obviousness of the invention[1].

Competitor Patents

Analyzing competitor patents in the same field can provide insights into the competitive landscape. Tools like PatentsView and other visualization platforms can help in mapping the patent landscape, identifying key players, and understanding the state of the art in metabolic disorder treatments[4].

Searching and Accessing Patent Information

USPTO Resources

The USPTO offers several resources for searching patents, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. This tool provides enhanced access to prior art and is essential for conducting thorough patent searches[1].

International Patent Databases

To ensure global coverage, it is important to search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Legal and Policy Considerations

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact how patent disputes related to US 9,352,025 are handled. Such a court would aim to provide a more streamlined and cost-effective process for resolving patent infringement cases[2].

Office Actions and Examination Data

The Patent Examination Data System (PEDS) and Office Action Indicators available through the Global Dossier service can provide insights into the examination process and any office actions related to the patent. This information can be valuable for understanding the patent's validity and potential challenges[1].

Practical Applications and Implications

Commercial Use and Licensing

Understanding the scope and claims of US Patent 9,352,025 is crucial for any entity considering commercial use or licensing of the invention. Ensuring that any use or modification does not infringe on the patent is essential to avoid legal repercussions.

Research and Development

For researchers and developers in the field of metabolic disorders, analyzing the patent landscape and the specific claims of US 9,352,025 can guide future research and development efforts. It helps in identifying areas that are not yet protected by existing patents.

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Patent Classification: Using classification systems to identify similar patents and technologies.
  • Prior Art and Citation Data: Utilizing tools like CCD and Global Dossier to understand the novelty and non-obviousness of the invention.
  • Competitor Patents: Analyzing competitor patents to understand the competitive landscape.
  • Legal Considerations: Being aware of potential legal frameworks such as small claims patent courts and office actions.

FAQs

What is the primary focus of United States Patent 9,352,025?

The primary focus of US Patent 9,352,025 is a method for treating metabolic disorders using specific therapeutic approaches.

How can I access the full text of US Patent 9,352,025?

You can access the full text of US Patent 9,352,025 through the USPTO's Patent Public Search tool or other patent databases like Unified Patents Portal[1][5].

What is the significance of patent classification in analyzing US Patent 9,352,025?

Patent classification helps in organizing patents into specific technology groupings, making it easier to identify similar patents and technologies in the metabolic disorder treatment field[4].

How can I determine if a new method falls within the scope of US Patent 9,352,025?

To determine if a new method falls within the scope, you need to compare the new method against the claims of US Patent 9,352,025, ensuring that it does not infringe on any of the independent or dependent claims.

What resources are available for searching international patent databases?

Resources like the European Patent Office's esp@cenet, Japan Patent Office's database, and WIPO's PATENTSCOPE ® Search Service provide access to international patent databases[1].

Sources

  1. USPTO: Search for patents - USPTO.
  2. ACUS: U.S. Patent Small Claims Court.
  3. USPTO: Patent Claims Research Dataset.
  4. Brown University Library Guides: Home - Patents - Library Guides at Brown University.
  5. Unified Patents Portal: US-9352025-B2 - Unified Patents Portal.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,352,025

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 9,352,025 ⤷  Subscribe ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ADMINISTERING BROMOCRIPTINE MESYLATE AND A FIRST-PHASE INSULIN SECRETAGOGUE AS RECITED IN CLAIMS 1-5 AND WHEREIN THE EFFECTS ARE AS RECITED IN CLAIMS 1-5 ⤷  Subscribe
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 9,352,025 ⤷  Subscribe ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES BY ADMINISTERING BROMOCRIPTINE MESYLATE AND A FIRST-PHASE INSULIN SECRETAGOGUE AS RECITED IN CLAIM 7 AND WHEREIN THE EFFECTS ARE AS RECITED IN CLAIM 7 ⤷  Subscribe
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 9,352,025 ⤷  Subscribe ADJUNCT TO DIET AND EXERCISE TO TREAT GLUCOSE INTOLERANCE IN ADULTS WITH TYPE 2 DIABETES BY ADMINISTERING BROMOCRIPTINE MESYLATE AND A FIRST-PHASE INSULIN SECRETAGOGUE AS RECITED IN CLAIMS 14-15 AND WHEREIN THE EFFECTS ARE AS RECITED IN CLAIMS 14-15 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.